Current location:opinions >>
The cancer drugs that could improve survival rates if given to patients in the morning
opinions935People have gathered around
IntroductionGiving cancer patients immunotherapy early in the morning rather than in the afternoon could improve ...
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates.
A study has found that people with terminal lung or skin cancers lived twice as long if they received immunotherapy drugs — which help the immune system destroy cancer cells — at the start of the day instead of after lunchtime.
The best results were seen in those treated at about 7.30am. They lived on average another two-and-a-half years.
The researchers who led the trial, published in the European Journal of Cancer, think this may be due to the immune system being more active very early in the day.
Previous studies found there are higher levels of immune cells circulating in the blood in the early morning.
Giving cancer patients immunotherapy early in the morning rather than in the afternoon could improve survival rates, a new study has found (Stock Image)
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths. Pictured: A graphic showing cancer cells
As well as fighting off viruses and bacteria, these can attack cancer cells.
It's thought this is due to the circadian rhythm — our body clock — getting the immune system ready to face any daytime threats from infectious agents, such as in food or transmitted via interacting with people around us.
READ MORE: Alarm over insulin shortage as Brits battling type 1 diabetes fear they'll 'die within days' without access to life-saving drug
AdvertisementImmunotherapy drugs, such as ipilimumab, pembrolizumab and nivolumab, have transformed cancer care in the UK over the past decade or so.
Since 2011 when the first immunotherapy drugs were licensed in the UK for the treatment of malignant melanoma (the most dangerous form of skin cancer), average survival time has risen from six months to five years or more.
Most of these drugs — which can cost up to £100,000 per patient per year — work by attaching to a protein called PD-L1, which is produced in large quantities by cancer cells.
The protein switches off T-cells, defender cells released by the immune system, rendering them unable to attack the cancer.
Immunotherapy drugs stop the proteins from binding to T-cells, effectively turning the immune system back on, enabling it to seek and destroy cancerous growths.
The theory is that giving immunotherapy at the start of the day would supercharge this response, as there are more T-cells circulating then.
This follows previous research that showed people given the flu vaccine early in the day produced much higher levels of antibodies than those given the jab later.
Again, the thinking is that the immune system is more active then, so responds much more vigorously to vaccines.
The researchers, from a number of bodies in France — including the PSL Research University in Paris — analysed data from 361 patients with lung or skin cancer that had spread and who were treated with immunotherapy drugs between 2015 and 2021.
Their survival rates were compared with the usual time each patient received treatment — most had roughly the same slot every week or two weeks.
The theory is that giving immunotherapy at the start of the day supercharges a person's immune response, as there are more T-cells then. Picture: Molecular model of an antibody
The results showed those treated before noon survived an average of 30 months; after that average survival was 15.9 months.
Earlier studies also involving the timing of cancer treatments reached similar conclusions.
Now two larger trials are under way in China and the U.S. to see if more lives could be saved just by giving drugs in the morning. The results are expected in the next couple of years.
Dr Pasquale Innominato, a cancer specialist at Ysbyty Gwynedd Hospital in Bangor, Wales, who is also researching the effect of earlier drug delivery, said the findings have the potential to shake-up NHS patient care.
'We need to see results from the bigger trials, but all the evidence so far shows that, whatever type of immunotherapy drug is used and whatever type of cancer it is, there are benefits from giving treatment earlier in the day.'
Tags:
Reprint:Friends are welcome to share on the Internet, but please indicate the source of the article when reprinting it.“International Infusion news portal”。http://guam.prpsystems.net/article-62c899084.html
Related articles
Messi in and Dybala out in Argentina squad for pre
opinionsBUENOS AIRES, Argentina (AP) — Lionel Messi is in and Paulo Dybala is out of Argentina’s squad for f ...
【opinions】
Read moreGisele Bundchen exudes sporty chic in an all
opinionsGisele Bündchen looked every inch the doting dog mom while talking her beloved German Shepherd, Alf ...
【opinions】
Read moreWhat are the most memorable Kentucky Derby races?
opinionsA look at 10 memorable editions of the Kentucky Derby, with the 150th running coming up on Saturday: ...
【opinions】
Read more
Popular articles
- ‘The Blue Angels,’ filmed for IMAX, puts viewers in the ‘box’ with the elite flying squad
- CVS Health chops 2024 forecast as cost struggles with Medicare Advantage persist
- Twins center fielder Byron Buxton leaves game against White Sox with sore right knee
- Lisa Kudrow, 60, cuts a youthful figure as she films new Netflix show No Good Deed in LA
- This Week: Home sales, Fed meeting minutes and consumer sentiment index
- Columbia University student journalists had an up
Latest articles
What a blast to work at NASA. Space agency is sky
Small ranching community tears itself apart as newly
George W. Bush's portraits of veterans are heading to Disney World
National 3
The 13 style rules that every midlife woman MUST follow (and yes, beige really is banned!)
EastEnders heartthrob looks completely unrecognisable as he displays his ripped physique
LINKS
- North Korea files short
- No rest for Rodgers! Controversial New York Jets quarterback continues Achilles recovery with early
- No rest for Rodgers! Controversial New York Jets quarterback continues Achilles recovery with early
- Fans fear for one Irwin 'family member' as she vanishes from their socials: 'What has happened?'
- Jokic, Gilgeous
- David Beckham moves wife Victoria to tears with emotional speech at her star
- We're sleep experts
- The flooded housewives of Dubai: Chanel underwater, supercars swept away and mega
- Paris Hilton puts on a VERY leggy display in pink PVC dress as she shares new collaboration with Tan
- Alcaraz and Nadal continue recovery from injuries at Madrid Open while Djokovic skips tournament